Leo takes topical JAK inhibitor into phase 3 eczema program XPhyto plans pivotal trial of Parkinson's patch to challenge UCB MDimune inks mRNA vaccine and therapy delivery deal Progenity gets IBD Ventures Fund support for drug delivery tech The top 10 medtech VC rounds of 2020 Featured Story | By Nick Paul Taylor Leo Pharma has begun a phase 3 clinical trial of its topical pan-JAK inhibitor. The study will assess the ability of delgocitinib cream to improve outcomes in patients with moderate to severe chronic hand eczema. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor XPhyto has outlined plans to move its rotigotine transdermal patch into a pivotal clinical trial. The Canadian company committed to further development of the rival to UCB’s Neupro after completing a bioavailability pilot study of the Parkinnson’s patch. read more By Nick Paul Taylor MDimune has landed a deal to use its cell-derived vesicle platform in the delivery of mRNA vaccines and therapies. The deal sees MDimune team up with its Korean compatriot Reyon Pharmaceuticals for a multi-indication collaboration. read more By Nick Paul Taylor Progenity has secured funding from the Crohn’s & Colitis Foundation’s IBD Ventures Fund for use in the development of a drug delivery system for inflammatory bowel disease. read more By Andrea Park In 2020, medtech companies raked in $6.4 billion in venture funding, quite a bit above the $5.7 billion investors poured into the sector in 2019. Here’s how they split the pot—and what each company is doing now to top a record-setting year. read more Resources Sponsored By: Veeva Learn how to develop a standards program that has your full team’s buy-in and improves the efficiency and quality of your clinical trials. Sponsored By: Veeva One top 10 pharma outlines three key steps to launching a modular content strategy to generate localized content faster. Sponsored By: Blue Matter This 77-page e-book explores 7 keys to success that any biopharma company needs to keep in mind as it enters Europe. Sponsored by: Datacubed Health The average clinical trial spends $40,000 per patient. Yet despite these high costs, most trials struggle to retain patients. Sponsored By: AmerisourceBergen Developing a quality product and getting it approved for distribution is not enough to guarantee commercial success. Sponsored By: WCG Trifecta The new standards in study training help sponsors and CROs reduce costs by 60%, cut training time by 50%, and start enrollment 55 days faster – learn more today. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process intesification Sponsored By: August Bioservices How has COVID-19 impacted CRO/CDMO customer (dis)satisfaction and outsourcing decisions for pharma and biotech companies in 2021 and beyond? Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: BC Platforms Those wishing to unlock RWD’s true value must have access to a variety of data sources/types and the technological capabilities to use the data to uncover meaningful insights. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Next Gen: What’s beyond the leading edge of biotech and pharma? June 22-23, 2021 | Virtual Event | 